Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. FDA to weigh easing limits on unproven peptides FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC FDA mulls compounding for peptides previously flagged over safety risks BioSpace